This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 10/12/2020
Location: Virtual
Subject: HLTH VRTL 2020; Keynote Speaker: The Meticulous Work of the FDA
FDA Participant/Group: AMY ABERNETHY; COLIN ROM;
Non FDA Participant/Group: Industry, government, media, academia and other registered guests

Event Date: 10/13/2020
Location: Virtual
Subject: Reagan-Udall Foundation Annual Public Meeting: From Anomaly to Precedent: How our COVID-19 Response Shapes the Future of Public Health; Speaker: Remarks and Question and Answer Session
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, media, academia and other registered guests

Event Date: 10/16/2020
Location: Virtual
Subject: American Medical Association 2020 Medical Student Session National Advocacy Week
FDA Participant/Group: COLIN ROM; DAYLE CRISTINZIO;
Non FDA Participant/Group: Several members of the American Medical Association Medical Student Section

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 10/12/2020
Location: Virtual
Subject: Galien Foundation: Digital Health Improving Research and Care
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 10/13/2020
Location: Virtual
Subject: HLTH VRTL 2020; Panel: Battling COVID-19 with Data and Science
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 10/13/2020
Location: Virtual
Subject: Regan-Udall Foundation Annual Public Meeting; Panelist: From Anomaly to Precedent: How our COVID-19 Response Shapes the Future of Public Health
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Academia, industry, patient groups, and other stakeholders

Event Date: 10/14/2020
Location: Virtual
Subject: Demy-Colton Virtual Salon Series: Fireside Chat with Dr. Amy Abernethy
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 10/14/2020
Location: Virtual
Subject: Premier Webinar - COVID-19 Updates: Back to Health
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry and other invited guests

Event Date: 10/14/2020
Location: Virtual
Subject: Sentinel Public Workshop; Fireside Chat with Dr. Abernethy
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and other stakeholders

Event Date: 10/15/2020
Location: Virtual
Subject: POLITICO Artifical Intelligence (AI) Summit; Cracking COVID with AI: Power Player Interview
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, media, and other stakeholders

Event Date: 10/15/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, health care providers, industry, academia, and other stakeholders

Event Date: 10/16/2020
Location: Virtual
Subject: CBD Policy Working Group Listening Session with Bazelet Health Systems and Cornell University
FDA Participant/Group: JENIFER ROE; APRIL ALEXANDROW; DOMINIC CHIAPPERINO; SHARON MAYL; KAVEETA VASISHT; DOUGLAS THROCKMORTON; RACHEL OSTERMAN; CASSANDRA TAYLOR; KAREN MEISTER;
Non FDA Participant/Group: David Grand, Jahan Marcu, Michael Eluzfon (Bazelet Health); Gary Hennen (Oglesby Plants International); Ali Abbaspourrad, Marius Weigert, Younas Dadmohammadi (Cornell University);

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 10/14/2020
Location: Virtual
Subject: Association of Food and Drug Officials Smarter Food Safety Webinar
FDA Participant/Group: Several FDA senior officials and staff
Non FDA Participant/Group: Members of the food industry, academia, state, and federal government

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 10/14/2020
Location: Virutal
Subject: Romaine Lettuce
FDA Participant/Group: DONALD PRATER
Non FDA Participant/Group: Alison Orr, Daniel Burgoyne, Isabella Laberge (Canadian Food Inspection Agency (CFIA));

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/13/2020
Location: Virtual
Subject: Health Evolutions; Speaker: The Race for a Vaccine: Regulatory Policymaking and Expedited Clinical Trial Innovation
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 10/13/2020
Location: Virtual
Subject: Univeristy of Florida, Undergraduate Guest Lecture; Speaker: Regenerative Medicine from FDA Perspective
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia and other invited guests

Event Date: 10/14/2020
Location: Virtual
Subject: Alliance for Regenerative Medicine (ARM) Cell & Gene Meeting on the Mesa; Speaker: FDA Perspective
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 10/15/2020
Location: Virtual
Subject: 2020 Virtual American Association of Tissue Banks (AATB) Annual Meeting; Speaker: CBER Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event